SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-14-000678
Filing Date
2014-03-11
Accepted
2014-03-11 06:03:57
Documents
19
Period of Report
2014-03-10
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8k.htm 8-K 21722
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 12484
3 GRAPHIC image_001.jpg GRAPHIC 43832
4 GRAPHIC image_002.jpg GRAPHIC 131873
5 GRAPHIC image_003.jpg GRAPHIC 71506
6 GRAPHIC image_004.jpg GRAPHIC 39672
7 GRAPHIC image_005.jpg GRAPHIC 74733
8 GRAPHIC image_006.jpg GRAPHIC 64559
9 GRAPHIC image_007.jpg GRAPHIC 56326
10 GRAPHIC image_008.jpg GRAPHIC 97126
11 GRAPHIC image_009.jpg GRAPHIC 65163
12 GRAPHIC image_010.jpg GRAPHIC 77805
13 GRAPHIC image_011.jpg GRAPHIC 74472
14 GRAPHIC image_012.jpg GRAPHIC 74897
15 GRAPHIC image_013.jpg GRAPHIC 71506
16 GRAPHIC image_014.jpg GRAPHIC 27359
17 GRAPHIC image_015.jpg GRAPHIC 25388
18 GRAPHIC image_016.jpg GRAPHIC 91882
19 GRAPHIC image_017.jpg GRAPHIC 77171
  Complete submission text file 0001493152-14-000678.txt   1643430
Mailing Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130
Business Address 12626 HIGH BLUFF DR. SUITE 150 SAN DIEGO CA 92130 858-704-4040
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 14682709
SIC: 2834 Pharmaceutical Preparations